Angiotensin II AT1 receptor antagonists and platelet activation

Nephrology Dialysis Transplantation

Volumn 16, Issue , 2001, Pages 45-49

  López Farré, Antonio ^a   Sánchez de Miguel, Lourdes ^a   Montón, Mercedes ^a   Jiménez, Ana ^a   Lopez Bloya, Almudena ^a   Gómez, Juan ^a   Núñez, Antonio ^a   Rico, Luis ^a   Casado, Santos ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Angiotensin; AT1 receptors; Platelets; Thromboxane A2; Thrombus

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG METABOLITE; IRBESARTAN; LISINOPRIL; LOSARTAN; PADGEM PROTEIN; PROSTAGLANDIN RECEPTOR; THROMBOXANE A2 DERIVATIVE; THROMBOXANE A2 RECEPTOR; TRITIUM; VALSARTAN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL SURFACE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG MECHANISM; ENDOTHELIUM CELL; ERYTHROCYTE; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STROKE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS; VASOCONSTRICTION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; CORONARY DISEASE; CORONARY THROMBOSIS; HUMANS; LOSARTAN; P-SELECTIN; PLATELET ACTIVATION; PLATELET AGGREGATION; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, THROMBOXANE; TETRAZOLES; THROMBOSIS; THROMBOXANE A2; VALINE;

EID: 0035001701     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.suppl_1.45     Document Type: Article

References (29)

1. Thromboregulation: Multicellular modulation of platelet reactivity in hemostasis and thrombosis
2. Thrombosis and inflammation as a multicellular process: Pathophysiologic significance of transcellular metabolism
3. Trombosis y enfermedad coronaria: Neutrófilos, óxido nítrico y aspirina
4. The pathogenesis of atherosclerosis. A perspective for the 1990s
5. Platelet-leukocyte-endothelial interaction in coronary artery disease
6. Neutrophil interactions with endothelium and platelets: Possible role in the development of cardiovascular injury
7. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets
8. Mechanisms leading to myocardial infarction: Insights from studies of vascular biology
9. Platelet-endothelium interactions
10. Platelet arachidonic acid metabolism
11. Multicellular eicosanoid and other metabolic interactions of platelets and other cells
12. Signalling through G proteins and G protein-coupled receptors during platelet activation
13. Aspirin as an antiplatelet drug
14. Pharmacology of platelet inhibition in humans: Implications of the salicylate-aspirin interaction
15. Characterization and chromosomal mapping of the human thromboxane A2 receptor gene
16. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II: Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function
17. Identification of AT1 receptors on human platelets and decreased angiotensin II binding in hypertension
18. Clopidrogrel
19. Angiotensin receptor antagonists: Focus on losartan
20. Nonpeptide angiotensin II receptor antagonist VIII. Characterization of functional antagonist displayed by DuP 753, an orally active antihypertensive agent
21. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries
22. Prevention of thromboxane A2 receptor-mediated antagonist
23. Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats
24. Effects of losartan on contractile responses in conductance and resistance arteries from rats
25. Effect of losartan on human platelet activation
26. Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist in patients with essential hypertension
27. Angiotensin II receptor antagonists: Potential in elderly patients with cardiovascular disease
28. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation
29. AT2 stimulation increases aortic cyclic GMP in SHR-SP by a kinin-dependent mechanism